Copyright © 2021 EnBiotix, Inc.. All Rights Reserved

Biotech companies are driving the fight against bacteria

Full Article | October 22nd, 2019


Fighting the Dangerous Increase of Multidrug-Resistant Microbes

Full Article | June 3rd, 2019

Forbes: Just How Smart Is Smart Medicine? MIT Scientists Are About To Find Out

Full Article | April 10th, 2018

CF News Today: Two-compound EBX-001 Eliminates Bacteria Better Than Its Antibiotic Part Alone, Study Reports

Full Article | October 4th, 2017


Boston Globe: Just months after expanding, LabCentral growing again

Full Article | September 21st, 2017


Full Article | February 23rd, 2017


The Atlantic: In Bacteria, Persistence Leads to Resistance

Full Article | February 9th, 2017


Wyss Institute: Firing up bacterial metabolism to fight antibiotic resistance

Full Article | February 6th, 2017


The Pharma Letter: EnBiotix acquires anti-microbial peptide portfolio from AMP

Full Article | November 3rd, 2016


BioPharm Dive: EnBiotix gets the bug for AMPT antimicrobials

Full Article | November 3rd, 2016


EnBiotix, Elanco team up to offer antibiotic alternatives for animal production

Full Article | June 30th, 2016


Elanco forms research pact to explore antibiotics alternatives

Full Article | June 22nd, 2016


Elanco Explores Antibiotic Alternatives Through Partnership with EnBiotix

Full Article | June 21st, 2016

Gates Foundation Highlights EnBiotix Among Awardees of Grand Challenges Explorations Round 16

Full Article | May 25th, 2016

Discover Magazine: An Energetic Solution: A boost to bacteria’s metabolism could help thwart antibiotic resistance.

Full Article | February 24th, 2016

Xconomy: From Dance Clubs to Syn Bio: MIT’s Collins on Startups, Second Chances

Full Article | October 5th, 2015


Science Magazine: Synthetic Biology’s Clinical Applications

Full Article | September 25th, 2015

Massachusetts Life Sciences Center Announces New Round of Cooperative Research Matching Grants

June 26th, 2015

Yale Scientific: Unsolved Mysteries: The Enigmatic Mechanism of Age-old Antibiotics

Full Article | January 18th, 2015

New Worker Magazine: LabCentral: It takes a village to start a company

Full Article | January 5th, 2015

Marketplace Business: Merck invests in new antibiotics

Full Article | December 8th, 2014

Start-up! Magazine: Antibiotics: Officially Encouraged, Increasingly Precise, Still Risky

Full Article | October 23rd, 2014

Design&Trend: How Antibiotics Kill Bacteria

Full Article | October 13th, 2014

NOVA (PBS): The Diseaseome Could Take Medicine Beyond the Genome

Full Article | October 9th, 2014

Al Jazeera America: Defeating the superbugs: New inventions to kill drug-resistant disease

Full Article | May 22nd, 2014

Science News: Unsolved Drugs

Full Article | April 18th, 2014

The Scientist: Overcoming Resistance

Full Article | April 1st, 2014

Cost Drivers: Antibiotics will attract Pharmaceutical Investment

Full Article | January 27th, 2014


Wall Street Journal: Drug Makers Tiptoe Back Into Antibiotic R&D

Full Article | January 1st, 2014

BioWorld: EnBiotix Inc.: Antibiotic Helpers for Resistant, Persistent Bugs

Full Article | November 18th, 2013


Genetic Engineering and Biology News: Biopharmas Drive Antibiotic Development

Full Article | August 14th, 2013

Nature Biotechnology: Startups on the Menu: EnBiotix

Full Article  | March 21st, 2013

BioCentury: EnBiotix: Enhancing Antibiotics

Full Article | February 11th, 2013



Full Article | January 18th, 2013

Boston.Com: New approach identifies sidekick drug to help antibiotics defeat infections

Full Article | January 6th, 2013

Terrier Tech: BU New Venture, EnBiotix to engineer next generation antibiotics

Full Article | June 18th, 2012